By a News Reporter-Staff News Editor at Clinical Trials Week A patent application by the inventor Hughes, Patrick M., filed on November 21, 2016, was made available online on March 16, 2017, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application has not been assigned to a company or instit
By a News Reporter-Staff News Editor at Pharma Business Week A patent application by the inventors Ioffe, Vladimir; Ulanenko, Konstantin; Laxer, Avital; Safadi, Muhammad; Licht, Danit; Lovinger, Ioana; Fristedt, Ulf Tomas, filed on November 17, 2016, was made available online on March 16, 2017, according to news reporting originating from Washing
By a News Reporter-Staff News Editor at Pharma Business Week A patent application by the inventors ST. LAURENT, Joseph P.; JONES, Gerald S.; BRESSE, David M., filed on September 9, 2016, was made available online on March 16, 2017, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application has
By a News Reporter-Staff News Editor at Pharma Business Week A patent application by the inventor IENAGA, Kazuharu, filed on February 25, 2015, was made available online on March 16, 2017, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application is assigned to Nippon Zoki Pharmaceutical Co.,
By a News Reporter-Staff News Editor at Clinical Trials Week Researchers from the Wellcome Trust Sanger Institute and their collaborators have discovered that a greater number of breast cancers are genetically similar to rarer cases with faulty BRCA1 or BRCA2 genes. The results published in Nature Medicine open up the possibility of up to 20 per
By a News Reporter-Staff News Editor at Managed Care Weekly Digest PITTSBURGH, A key component of the Affordable Care Act successfully saved Medicare $345 per person in medical costs in its first year without driving up prescription drug coverage costs, according to an analysis led by the University of Pittsburgh Graduate School of Public Health.
By a News Reporter-Staff News Editor at Clinical Trials Week Active Implants, LLC, a company that develops orthopedic implant solutions, announced that it completed the first $10 million tranche of a $40 million Class D Units financing. The financing is to be comprised of $30 million from first-time investor LS Health Science Partners, L.P., with
DUBLIN and BOSTON, March 27, 2017/ PRNewswire/ Allergan plc,, a leading global pharmaceutical company and Paratek Pharmaceuticals, Inc., a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon tetracycline chemistry, announced that two Phase 3 trials of sarecycline for the treatment of moder
WASHINGTON- Allergan plc and Paratek Pharmaceuticals Inc. announced that two Phase 3 trials of sarecycline for the treatment of moderate to severe acne met their 12 week primary efficacy endpoints. Based on these data, Allergan plans to file a New Drug Application to the U.S. Food& Drug Administration in the second half of this year. said David Nic
By a News Reporter-Staff News Editor at Clinical Trials Week Altasciences Clinical Research proudly announces that its companies, Algorithme Pharma and Vince& Associates Clinical Research, have each been awarded multiple 2017 CRO Leadership Awards. This is the fourth consecutive year that Algorithme Pharma has been recognized by the industry.
Trusted Health Plan Inc., a Washington D.C. headquartered Managed Care Organization announces the acquisition of Harbor Health Plan, Inc. Plans include building brick and mortar Wellness Centers in Wayne, Oakland, and Macomb counties to improve member health outcomes, and establishing value-based contracts with providers. The Wellness Centers wil
APEIRON Biologics AG today announced that the European Medicines Agency's Committee for Medicinal Products for Human Use has adopted a positive opinion recommending the approval of dinutuximab beta for immunotherapy of high risk neuroblastoma. The development was extended to multiple clinical trials across Europe and abroad, performed by the SIOPEN
ArQule, Inc. today reported that its partner, Kyowa Hakko Kirin, announced top-line results of the JET-HCC Phase 3 trial of tivantinib in Japan, and that the trial did not meet its primary endpoint of progression free survival. I would like to thank our partner, Kyowa Hakko Kirin, and all the participants in their study, said Paolo Pucci, Chi
By a News Reporter-Staff News Editor at Clinical Trials Week Asana BioSciences, LLC, a clinical stage biopharmaceutical company, announced that the FDA has accepted the IND application for ASN002, a novel dual SYK-JAK inhibitor, for atopic dermatitis. "We are extremely pleased with the efficient execution of our strategy to work on clinically va
PUNE, MAHARASHTRA, INDIA, March 27, 2017/ EINPresswire.com/ Asia Pacific Wearable Medical Device Market including classification, application and industry chain overview; Then we deeply analyzed Asia Pacific growth forecast indicators by the as well as the regional market conditions that including the product price, profit, utilization, supply, d
Tragrisso, a drug developed by AstraZeneca plc (ADR) (NYSE:AZN), has been granted approval in China. The treatment is designed to assist patients who are suffering from cancer and who have particular genetic mutations that are commonly found in the world's most populous country. China's approval of Tagrisso not only boosts the prospects of Astr
Aurinia Pharmaceuticals Inc., a clinical stage biopharmaceutical company focused on the global immunology market, today announced the 48- week results from the Aurinia Early Urinary Protein Reduction Predicts Response Study open-label study of voclosporin for the treatment of lupus nephritis at the 12 th International Congress on Systemic Lup
By a News Reporter-Staff News Editor at Clinical Trials Week Boston Biomedical Associates will be one of the lead presenters and sponsors at the annual Outsourcing in Clinical Trials Israel conference in Tel Aviv March 21-22, 2017. Tami Abudi, the Co-CEO and Clinical Director of BBA Ltd. Israel, will present a program entitled "Outlining Global..
Bracco Diagnostics Inc., the U.S. subsidiary of Bracco Imaging S.p.A., a leading global company in the diagnostic imaging business, today announced the launch of its PROTOCO 2 L TOUCH Colon Insufflator. In the U.S., colon cancer is a leading cause of cancer related deaths. "The USPSTF Grade A classification places CTC on par with optical colonos
By a News Reporter-Staff News Editor at Clinical Trials Week Houston- based biotechnology company HYPERLINK " http://www.celltexbank.com/"\ nCelltex Therapeutics Corporation announces that Stem Cells and Development has published "HYPERLINK" http://online.liebertpub.com/doi/abs/10. 1089/ scd.2016.0196 "\ nAutologous Adipose Stem Cell Therapy for.
By a News Reporter-Staff News Editor at Robotics& Machine Learning Corindus Vascular Robotics, Inc. announced that WakeMed Health& Hospitals will partner with Corindus to develop a national center of excellence to advance patient care and clinical robotics research and to train interventional cardiologists on robotic-assisted percutaneous coronar
Cosmo announces further expansion of endoscopy pipeline with filing for EU approval of New Medical Device Qolotag to enhance diagnosis in sigmoidoscopies. Dublin- March 27, 2017- Cosmo Pharmaceuticals N.V. today announced that it has filed for EU approval of its new medical device named Qolotag. Approval is expected within June 2017 and marketing w
According to the latest report published by Credence Research, Inc. "Telehealth Market- Growth, Future Prospects and Competitive Analysis, 2016- 2022," the telehealth market was valued at USD 2,193.1 Mn in 2015, and is expected to reach USD 10,467.0 Mn by 2022, expanding at a CAGR of 24.7% from 2016 to 2022.. Phenomenal rise in the aging and chroni
The latest market report published by Credence Research, Inc. "Global Teleradiology Market- Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016- 2023," the Global Teleradiology market was valued at USD 3,200.6 Mn in 2015, and is expected to reach USD 10,841.0 Mn by 2023, expanding at a CAGR of 16.5% from 2016 to 2023.. Browse the
By a News Reporter-Staff News Editor at Clinical Trials Week HYPERLINK " http://www.cytosorbents.com/"\ n CytoSorbents Corporation, manufacturer of the HYPERLINK " http://www.cytosorb.com/"\ nCytoSorb extracorporeal blood purification therapy that reduces excessive levels of inflammatory mediators in critically-ill and cardiac surgery patients